Latest Regulatory News

Ore Resources Ltd has identified nine promising gold targets at its Randalls North tenements through detailed geophysical and geochemical analysis, setting the stage for an active 2026 exploration campaign.

Tetratherix has successfully completed the second safety review of its TetraDerm clinical trial's second cohort, showing no adverse events and confirming a strong safety profile. The trial now progresses to its final phase, targeting a growing reconstructive surgery market.

Forrestania Resources has agreed to acquire Catalina Resources’ Laverton Project, swapping its Breakaway Dam copper asset and gaining a significant equity stake in Catalina. This move strategically broadens Forrestania’s presence in the Eastern Goldfields gold belt.

Miramar Resources is set to launch a multi-commodity drilling campaign in early 2026, focusing on gold targets near Kalgoorlie and high-grade copper-lead-silver mineralisation in the Gascoyne region.

Lunnon Metals reports standout drilling results at Lady Herial, revealing thick, high-grade gold mineralisation beyond current open pit plans and setting the stage for expanded mining activity.

The Takeovers Panel has declined to investigate allegations of undisclosed shareholder associations at Cyclone Metals, following a contentious director removal. This decision signals regulatory confidence in the company’s governance stability.

Apiam Animal Health has secured Foreign Investment Review Board approval for its acquisition by Adamantem Capital, paving the way for a crucial shareholder vote in February.

King River Resources has addressed recent share price and volume spikes, denying undisclosed information and highlighting its significant Tivan Limited holding and ongoing Tennant Creek exploration.

Elevra Lithium unveils a staged, accelerated expansion plan for its North American Lithium mine, aiming to increase spodumene concentrate production to 315ktpa by early 2029 while lowering operating costs.

Osmond Resources has raised A$6.6 million through a discounted placement to fund its 2026 work program targeting titanium, zircon, and rare earth extraction in Spain. The capital boost positions the company to progress its Orión EU Critical Minerals Project amid growing EU demand for local supply.

Ragusa Minerals has addressed recent unusual trading activity, confirming no undisclosed information while advancing its acquisition of a controlling stake in Pegasus Tel Inc. and the Purple Pansy Project in Arizona.

Nova Eye Medical has reported a record US$6.1 million in sales for the December 2025 quarter, driven by strong US demand and a 24% annual growth rate that outpaces the industry.